Sebastian Kreuz

Sebastian is an investment manager at the Boehringer Ingelheim Venture Fund (BIVF) where he is focusing on investments in the fields of immuno-oncology, regenerative medicine and infectious diseases. With more than 15 years of experience in drug discovery within the pharmaceutical industry, he has a strong scientific background in various disease areas and is familiar with a broad range of therapeutic modalities.

Sebastian started his industrial career in 2004 by joining BI as a Research Scientist in the Functional Genomics Group, where he established novel experimental platforms for exploration of new drug concepts. In the following years, Sebastian held various positions within BI’s R&D organization including responsibilities as Laboratory Head and Research Project Leader for drug discovery projects.

Before joining the BIVF Sebastian was developing and implementing an integrated R&D strategy for virus-based gene therapy within BI’s Research Beyond Borders department. Sebastian studied Technical Biology at the University of Stuttgart and holds a PhD in Molecular Biology and Immunology.